Large-scale isolation of CD133+ progenitor cells from G-CSF mobilized peripheral blood stem cells
- 1 January 2003
- journal article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 31 (1) , 17-22
- https://doi.org/10.1038/sj.bmt.1703792
Abstract
We have evaluated the feasibility of large-scale isolation of CD133+ progenitors from healthy mobilized adult donors for potential clinical use in autologous and allogeneic transplantation. A total of 11 healthy volunteer adult donors were mobilized with G-CSF. CD133+ stem cells were isolated from a single leukapheresis using the Clinimacs method. The median percentage of CD133 before positive selection was 0.75% (range 0.39-2.03%). After selection, the median purity and recovery was 94% (range 85.2-98.0%) and 69% (range 44-100%), respectively. The median log10 T-cell depletion obtained by CD133+ positive selection was 4.2 (range 3.8-4.7). The CD133+ progenitors were highly enriched in colony-forming units (CFU) and transplantation into NOD/SCID mice resulted in a high engraftment rate. Transplantation of sorted CD133+/CD34+ cells into NOD/SCID mice showed a higher engraftment compared to CD133-/CD34+ cells. Mobilized peripheral CD133+ stem cells can be purified in large scale for potential clinical use. The biological function of the cells is not impaired. The majority of the NOD/SCID repopulating cells are within the CD133+/CD34+ subpopulation. Therefore, clinical studies using purified CD133+ stem cells can be envisoned to further clarify the role of CD133+ stem cells in hematopoietic reconstitution after transplantation.Keywords
This publication has 16 references indexed in Scilit:
- Megadose transplantation of purified peripheral blood CD34+progenitor cells from HLA-mismatched parental donors in childrenBone Marrow Transplantation, 2001
- Allogeneic hematopoietic transplantation of CD34+ selected cells from an HLA haplo-identical related donor. A long-term follow-up of 135 patients and a comparison of stem cell source between the bone marrow and the peripheral bloodBone Marrow Transplantation, 2000
- Transplantation of highly purified HLA-identical sibling donor peripheral blood CD34+ cells without prophylactic post-transplant immunosuppression in adult patients with first chronic phase chronic myeloid leukemia: results of a phase II studyBone Marrow Transplantation, 2000
- Expression von AC133 vs. CD34 bei akuten Leukämien im Kindesalter*Klinische Padiatrie, 2000
- A frameshift mutation in prominin (mouse)-like 1 causes human retinal degenerationHuman Molecular Genetics, 2000
- Isolation of Highly Purified Autologous and Allogeneic Peripheral CD34+ Cells Using the CliniMACS DeviceJournal of Hematotherapy, 1999
- Treatment of High-Risk Acute Leukemia with T-Cell–Depleted Stem Cells from Related Donors with One Fully Mismatched HLA HaplotypeNew England Journal of Medicine, 1998
- A newly discovered class of human hematopoietic cells with SCID-repopulating activityNature Medicine, 1998
- AC133, a Novel Marker for Human Hematopoietic Stem and Progenitor CellsBlood, 1997
- A Novel Five-Transmembrane Hematopoietic Stem Cell Antigen: Isolation, Characterization, and Molecular CloningBlood, 1997